---
title: "EXEL: Q2 2026 revenues rose 10% year-over-year, with Zanza's CRC NDA under review and guidance trimmed"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295029392.md"
description: "Q2 2026 revenues grew to $629M, with CABO franchise up 10% year-over-year and global revenues up 13%. Zanza's CRC NDA is under review, with multiple pivotal trials advancing and a robust pipeline supporting long-term growth. Guidance was lowered due to a slower NET ramp.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-05T23:25:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295029392.md)
  - [en](https://longbridge.com/en/news/295029392.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295029392.md)
generator: "portal-rs"
---

# EXEL: Q2 2026 revenues rose 10% year-over-year, with Zanza's CRC NDA under review and guidance trimmed

Q2 2026 revenues grew to $629M, with CABO franchise up 10% year-over-year and global revenues up 13%. Zanza's CRC NDA is under review, with multiple pivotal trials advancing and a robust pipeline supporting long-term growth. Guidance was lowered due to a slower NET ramp.

Based on 

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [EXEL.US](https://longbridge.com/en/quote/EXEL.US.md)

## Related News & Research

- [Kuehn Law Encourages Investors of EXELIXIS, Inc. to Contact Law Firm](https://longbridge.com/en/news/296412097.md)
- [BMO Capital Markets Upgrades Exelixis (NASDAQ:EXEL) to "Hold"](https://longbridge.com/en/news/296478537.md)
- [BofA says buy these 16 growth stocks with strong earnings to diversify beyond AI](https://longbridge.com/en/news/296947640.md)
- [BETCO_DKK: Q2 saw 9% revenue growth, strong cash flow, and margin expansion, with guidance unchanged](https://longbridge.com/en/news/296599275.md)
- [Singapore accounting body inks AI deal with Indian counterpart](https://longbridge.com/en/news/296584995.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**